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ABSTRACT
Cytoplasmic Progestin Binding in Adipose Tissues,
and the Effect of Progestins on Food Intake,
Adiposity, and Lipoprotein Lipase Activity
(September, 1980)
Janet Martha Gray, B. A., Simmons College
M.S., University of Massachusetts
Ph.D., University of Massachusetts
Directed by: Professor George Wade
Ovarian hormones have multiple effects on food intake, body weight
and carcass composition in female rats. Changes in these parameters
are observed over the estrous cycle of the rat and can be induced by
experimentally manipulating hormone levels. Ovariectomy (OVX) results
in transient increases in food intake and body weight gain, with perm-
anent increases in body weight relative to gonadal ly-intact controls.
Estradiol benzoate (E2B) treatment transiently decreases food intake
and body weight gain in OVX animals, with E2B-treated animals having
lowered body weights than OVX controls. Neither progestins, progest-
erone nor R5020, had any effect on food intake when administered to
OVX animals. When administered to OVX, E2B-treated rats, both R5020
and progesterone attenuated the estrogen-induced anorexia and weight
loss. R5020 was as effective a progestin as was progesterone at much
lower doses.
Carcass composition analyses revealed that the only carcass com-
ponent which was significantly altered by hormone treatment was
carcass lipid content. Analysis of parametrial adipose tissue
IV
cellularity revealed that the hormone- induced changes in lipid content
were probably an effect on fat cell size, not number.
The synthetic "antiestrogen"
,
nafoxidine, fully mimicked the
effects of E2B, j_.e_.
, nafoxidine treatment to OVX rats resulted in
lowered food intake, body weight and carcass fat composition. As it
does with E2B-treated rats, progesterone attenuated these effects in
nafoxidine-treated animals.
Since a major change in carcass lipid content is found following
hormone administration, it was of interest to determine whether or not
there were steroid binding sites in adipose tissues. If these binding
sites could be demonstrated, it would indicate that hormones might have
direct effects on adipose tissue metabolism. Estrogen binding sites
previously had been demonstrated in adipose tissues. Using ('^H)R5020,
progestin binding sites were demonstrated in the cytoplasm of adipose
tissues from E2B-treated rats. The E2B-induced ( H)R5020 binding was
found to be high affininty (K^=8.5 x 10"^ ^M) and progestin specific.
Three progestins competed effectively for ( H)R5020 binding, with the
order of efficacy being R5020 > progesterone > 5a-dihydroprogesterone.
An estrogen, an androgen and a glucocorticoid were effective in
competing for ( H)R5020 binding only when they were present in very
high concentrations.
In vivo administration of progestins resulted in the depletion
of cytoplasmic progestin binding sites from adipose tissues
of E2B-primed OVX rats. Again the order of efficacy was R5020 >
progesterone > 5"a-dihydroprogesterone.
V
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( H)R5020 binding sites were found in all adipose tissues
studied. Regional differences in absolute levels of E2B-induced bind-
ing were found, as were differences in the magnitude of induction
of progestin binding sites. Further analyses revealed a significant
correlation between estrogen receptor concentrations and the magnitude
of induction of progestin receptors in specific adipose tissues.
Single injections of E2B, CI-628 or nafoxidine depleted adipose
tissue cytoplasmic estrogen binding sites and induced progestin
binding sites. Three days of nafoxidine treatment resulted in the
induction of about 50% ('^H)R5020 binding sites as compared with E2B.
In these same animals, nafoxidine lowered adipose tissue lipoprotein
lipase (LPL) activity at least as much as did E2B.
Although concurrent administration of progesterone (5 mg/day) to
E2B-treated animals increased LPL activity, no progesterone effect on
LPL activity was found in nafoxidine- treated animals.
These studies demonstrate that a major effect of progestin
administration is to alter body fat content. The binding data suggest
that progestins might have direct effects on adipose tissues. One
possible mechanism of action is progestin-induced alterations in
adipose tissue LPL activity. Changes in LPL activity do reflect
changes in fat content following E2B and progestin administration.
However, the data from the nafoxidine experiments indicate that the
progesterone-induced changes in LPL activity are not necessary for the
changes in food intake and body fat composition.
vi
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CHAPTER I
GENERAL INTRODUCTION
Ovarian hormones have multiple effects on regulatory behaviors,
body weight and body composition in female rats and other mammals
(for reviews, see Wade, 1976; Wade and Gray, 1979). With cyclic
variations in hormone titers over the natural estrous cycle of the
female rat, changes are seen in body weight and regulatory behaviors.
At proestrus, when estrogen titers are high, running wheel activity
is high; food intake is low; and body weight is reduced (Brobeck,
Wheatland and Strominger, 1947; ter Haar, 1972; Wang, 1923). During
diestrus, when estrogen levels are reduced, food intake and body
weight gain are increased (ter Haar, 1972).
Gonadectomy and Hormone Replacement Studies
Gonadectomy and hormone replacement studies indicate that the
changes in food intake and body weight gain can be mimicked by exper-
imentally altering hormone levels. Ovariectomy (OVX) results in a
transient hyperphagia and body weight gain and a permanent decrease
in running wheel activity. After 3-4 weeks, the increased food
intake subsides and body weight gain normalizes, with body weight
being maintained at about 20 percent higher than that of gonadal ly
intact animals (Tarttelin and Gorski, 1973). Estradiol treatment,
alone, reverses the effects of OVX in adult female rats, resulting
in a transient hypophagia and body weight loss, and a permanent
1
2increase in running wheel activity and decrease in body weight rela-
tive to OVX controls (Tarttelin and Gorski
, 1973; Wade, 1975; Zucker,
1969).
Treatment of OVX rats with progesterone, alone, has no effect on
body weight gain, running wheel activity, or food intake (Hervey and
Hervey, 1966; 1967). Concurrent treatment with both estradiol and
progesterone, on the other hand, results in reversal of the estradiol-
induced changes in food intake, running activity, and body weight gain
(Hervey and Hervey, 1967; Roberts, Kenney and Mook, 1972; Rodier, 1971;
Wade, 1975; Zucker, 1969).
The greatest change in carcass composition following the adminis-
tration of ovarian hormones is observed in the total carcass fat con-
tent (Galletti and Klopper, 1964; Hervey and Hervey, 1967; Leshner and
Collier, 1973). OVX doubles fat content while estradiol treatment
reverses the effect of castration of adiposity. Progesterone treatment
to OVX, estradiol -treated animals, in turn, reverses the effect of the
estrogen, leading to an increase in the total carcass fat content.
In the first series of experiments to be described in this dis-
sertation, some of these basic experiments demonstrating that ovarian
hormones affect food intake, body weight and carcass composition were
replicated and expanded. I was especially interested in the changes in
these measurements which were induced by progestins in OVX and OVX,
estradiol -treated animals. I examined the effects of two progestins,
the natural compound, progesterone, and the synthetic compound, R502o\
on food intake, body weight, carcass composition, adipose tissues
cellularity, and adipose tissue LPL activity were studied.
3R5020 was used in these metabolic studies for two reasons.
(1) R5020 has previously been shown to be a very potent progestin with
regards to inducing changes in uterine morphology (Philibert and
Raynaud, 1974) and the facilitation of female rat sexual behavior
(Blaustein and Wade, 1978). It was of interest, therefore, to see
how a highly potent progestin would affect these metabolic parameters.
(2) Biochemically, R5020 is also a highly potent progestin; it binds
to progestin receptors in uterus, vagina, pituitary and brain with a
much higher affinity than does progesterone (Blaustein and Wade,
1978; Blaustein and Feder, 1979; Leavitt et al. , 1977; MacLusky and
McEwen, 1978; Raynaud, 1977). For these reasons, radioacti vely
labelled R5020 has been extensively used in the past few years to
characterize progestin binding in these tissues. As I will be dis-
cussing below, ( H)R5020 was used to characterize progestin binding
in adipose tissues. It was of interest, therefore, to demonstrate
and study the physiological efficacy of the progestin, R5020, which
was also to be used in a series of in vitro biochemical studies.
Central Versus Peripheral Control of Hormone Effects
on Food Intake, Body Weight and Carcass Composition
Until recently, it had been widely assumed that ovarian
steroids exert their regulatory effects via the brain by directly
influencing behaviors and indirectly influencing metabolic processes
(Wade, 1976). There are steroid binding proteins (receptors) for
both estrogens and progestins in the hypothalamus (Blaustein and
4Feder, 1979; Eisenfeld, 1970; Eisenfeld and Axelrod, 1965; MacLusky
and McEwen, 1978), indicating that this brain area is a target organ
for ovarian steroids. Implants of estradiol in the anterior hypo-
thalamus-preoptic area increase running wheel activity while implants
into the ventromedial hypothalamus (VMH) decrease food intake
(Colvin and Kalkoff, 1971; Nunez, Gray and Wade, 1980; Wade and
Zucker, 1970). The VMH is also important in metabolic regulatory
processes (Powley, 1977). Effects of VMH modulation of metabolic
activities may be manifested via direct efferents to peripheral
target tissues such as the liver, endocrine pancreas and adipose
tissues (Havel, 1965; Sawchenko and Friedman, 1979; Woods and Porte,
1974). However, the VMH is not the sole site of hormone action in
controlling metabolic factors, as both OVX-induced obesity and
estrogen-induced anorexia are observed in rats with large VMH lesions
(Beatty et al. , 1975; King and Cox, 1973).
Some data also indicate that the body weight and composition
changes which are observed after ovarian steroid treatment are not
always accompanied by parallel changes in behavior. Hervey and
Hervey (1968) found that progesterone treatment to intact female rats
resulted in increased body weights, even when the normally occurring,
hormone-induced hyperphagia was prevented. Roy and Wade (1977)
reported that OVX rats had to be restricted to 80 percent of the pre-
surgical ad libitum food intake in order to prevent OVX-induced
increases in body weight gain. These authors also reported that the
decreased food intake seen during estradiol treatment was not suffi-
cient to produce the normally observed, estradiol -induced decrease in
5body weight gain (Roy and Wade, 1977). Pair-feeding of OVX animals
to OVX animals which were injected with estradiol benzoate (E2B) did
not result in a loss in weight. MER-25, a synthetic compound which
mimics the above effects of on food intake and body weight gain
(Roy and Wade, 1976; 1977), was without any estrogen-like effect
on running wheel activity. These data indicate that the observed
differences in weight gain between the pair-fed OVX and the OVX plus
animals were not merely a reflection of differences in general
activity (Roy and Wade, 1977).
These data indicate that, at least under some circumstances,
the changes in behavior following ovarian hormone administration may
not be of primary importance for the changes in body weight and
adiposity. We proposed (Wade and Gray, 1979) instead that ovarian
hormones might act directly on adipose tissues and other peripheral
tissues which are involved in triglyceride storage. In this way,
hormones could alter the availability of circulating, utilizable
(oxidizable) triglycerides, thus sparing other fuels (e.g. glucose,
Randle et al_. , 1963). Components of triglycerides can be utilized
by such tissues as muscles and the liver. Other studies have demon-
strated that altering metabolic fuel availability can change food
intake (Friedman and Striker, 1976). According to this hypothesis,
changes in food intake following hormone manipulation might be a
consequence, rather than a cause, of altered circulating metabolic
fuels, and that changes in body weight gain and carcass composition
might reflect direct peripheral, metabolic responses to ovarian
hormones
.
6Estrogens increase hepatic triglyceride synthesis (Chan elt al_.
,
1976; Kim and Kalkoff, 1975; 1978). Progesterone appears to have
either no additional effect (Kim and Kalkoff, 1975; 1978) or is
synergistic with estradiol with regards to hepatic hypertriglyceridemia.
Lipoprotein lipase (LPL) is the enzyme involved in the hydrolysis
of triglycerides for storage in adipose tissues (Scowet al_., 1972).
Changes in adiposity resulting from hormonal manipulations are
reflected in changes in adipose tissue LPL activity. That is, OVX
results in a two-fold increase in adipose tissue LPL activity while
estradiol treatment reduces it (Hamosh and Hamosh, 1975). Progesterone,
on the other hand, has no effect on adipose tissue LPL activity in OVX
rats which have not been treated with estrogens. In gonadal ly intact
(estrogen-secreting) rats, however, progesterone treatment signifi-
cantly increase adipose tissue LPL activity (Kim and Kalkoff, 1975;
1978; Steingrimsdottir, Greenwood and Brasel , 1980).
Adipose Tissue as a Target Organ for Ovarian Hormones
This hypothesis suggests that ovarian steroids should have
direct effects on peripheral tissues such as the liver and adipose
tissues. Since a major component of the changes in total body weight
following hormone administration are observed in carcass fat content,
we have been especially interested in studying the effects of natural
and synthetic hormones on adipose tissues.
7If adipose tissue is to be accepted as a bona fide target organ
for ovarian hormones, then it should comply with the current model of
steroid action (Gorski and Gannon, 1976; O'Malley and Means, 1974;
Yammamoto and Alberts, 1976). According to this model, steroid
hormones passively diffuse into all cells throughout the body. In
target tissues (such as uterus, pituitary, hypothalamus) the hormones
bind, with high affinity and steroid specificity, to receptor proteins
in the cytoplasm. The steroid-receptor complexes are translocated
to the nucleus where they associate with the chromatin. These nuclear-
receptor complexes cause the initiation of hormone-specific and tissue-
specific responses. These responses are manifested in altered nuclear
RNA synthesis followed by de novo cytoplasmic protein synthesis. For
a tissue to be considered as a steroid hormone target tissue,
therefore, it should contain (a) specific, high-affinity binding
sites for the hormone, (b) nuclear accumulation of the hormone-
receptor complex, and (c) hormone-induced changes in RNA and protein
synthesis
.
We have recently (Wade and Gray, 1978) demonstrated the presence
of estrogen-specific, high-affinity cytoplasmic protein binding sites
for 17e-estradiol in adipose tissues of female rats. We have also
demonstrated that there is an accumulation of labelled steroid in
3
the nuclei of adipose tissue cells following an injection of ( H)-
estradiol (Gray, Dudley and Wade, 1980). These data demonstrate that
adipose tissue might be a true target tissue for estrogens.
8One goal of the series of studies to be described was to demon-
strate and characterize progestin binding in the cytoplasm of adipose
tissues. One explanation for a lack of progestin-induced metabolic or
behavioral responses in the absence of estrogen stimulation could be
that estrogen pretreatment is necessary for the induction of pro-
gestin receptors. A similar prerequisite for estrogen for the
induction of progestin receptors has previously been demonstrated
(e.g. Leavitt et al. , 1977; MacLusky and McEwen, 1970; Raynaud, 1977).
Therefore, in addition to studying the affinity and specificity of
these progestin binding sites, I examined the presence and induction
of these binding sites under different estrogen (E2B) priming
3
conditions. As described earlier, ( H)R5020, a potent progestin-1 ike
substance which has been previously shown to bind tightly to progestin
receptors in other target tissues, was used in these binding studies.
Synthetic "Anti estrogens " : Estrogen Mimetic Effects on
Food Intake and Body Weight
Synthetic antiestrogens antagonize the effects of estrogen in a
variety of target organs including the vagina, oviduct, uterus,
mammary gland and brain (Gerall, Napoli and Cooper, 1973; Komisaruk
and Beyer, 1972; Lerner, 1964; Roy and Wade, 1975). However, the
synthetic antiestrogens, MER-25, clomiphene and nafoxidine, have
been shown to be estrogen-like in their suppression of food intake
and body weight gain (Poteat, 1977; Roy and Wade, 1976; Wade and
Blaustein, 1978). In addition, Roy and Wade (1976) have demonstrated
that progesterone could attenuate the food intake and body weight
9suppressing effects of MER-25.
Some recent data indicate that although antiestrogens mimic
the effects of estradiol on food intake and body weight, these same
compounds block estrogen-induced hypertriglyceridemia and do not
themselves induce raised levels of serum triglycerides (Chan et al_.
,
1976; Pageaux, et_ al. , 1980; Ramirez, unpublished observations).
These data indicate that blood triglyceride levels, £er se, may not
be the important factor in altering feeding behaviors following
hormone treatments.
Recent studies have shown that synthetic antiestrogens can
cause the induction of uterine, hypophyseal and hypothalamic
cytoplasmic progestin receptors (Jordan and Prestwich, 1978; Koseki
et_ al_.
, 1977; Roy, MacLusky and McEwen, 1979). However, the levels
of progestin receptors which are induced by the antiestrogens are far
lower than those levels observed following estradiol treatment.
Whether or not the progestin receptors which are induced following
antiestrogen administration are physiologically effective remains to
be determined. Following several days of estradiol plus antiestrogen
treatment, antiestrogens inhibit the estradiol -induced synthesis of
progestin receptors in the uterus (Roy, MacLusky and McEwen, 1979).
Antiestrogens also block the estrogen-induced synthesis of progestin
binding sites in hypothalamus-proptic area and pituitary, although,
alone, the antiestrogen produced a slight induction of binding sites
in these tissues (Roy, MacLusky and McEwen, 1979).
10
In order to more fully explore the effects of an antiestrogen
on food intake and metabolic processes, and the interaction of the
antiestrogen with progesterone on these measures, rats were injected
with nafoxidine, with or without concurrent progesterone. Measure-
ments were made of food intake, body weight, carcass composition,
serum triglycerides, wet and dry uterine weights, adipose tissue
progestin binding and adipose tissue LPL activity. These results
were compared with parallel data collected from rats which were
treated with plus or minus progesterone.
It was hypothesized that, if progestin-induced effects on
metabolic factors such as adipose tissue LPL activity are mediated
via hormone receptor complexes, there should be a correlation between
the amount of progestin receptor which is induced by a specific
estrogen or antiestrogen and the amount of reversal of the estrogen/
antiestrogen suppression in adipose tissue LPL activity following
progesterone treatment.
In summary, the general purpose of the studies which are
presented in this dissertation was to examine some of the behavioral,
metabolic and biochemical concommi tants of progestin administration
to OVX rats which had been concurrently treated with either no
estrogen, E2B, or the synthetic antiestrogen, nafoxidine. The goal
of these studies was to gain a better understanding of how ovarian
steroids exert effects on metabolic parameters in a mammalian model.
CHAPTER II
PROGESTIN EFFECTS ON BODY WEIGHT, FOOD INTAKE AND ADIPOSITY
As discussed in more detail in Chapter I, estradiol decreases
food intake, body weight and adiposity, while progesterone antagonizes
these estradiol -induced effects. One goal of the first series of
studies was to replicate and extend the basic studies on the effects
of ovarian hormones on food intake, body weight and adiposity.
The effects of estradiol benzoate (E^B) and progesterone (alone
and in combination) were determined with respect to food intake, body
weight, carcass composition, and adipose tissue cellularity (cell
size and number). The effects of administration of the potent
synthetic progestin, R5020, on these measures were also determined.
No previous metabolic studies have been reported using R5020, although
R5020 has been previously reported to be a highly effective progestin
with regard to several biochemical measures (e.g., Leavitt et al
.
,
1977; Raynaud, 1977; Philibert and Raynaud, 1974), as well as the
facilitation of female sexual behavior in rats (Blaustein and Wade,
1977).
Radioactively-labelled R5020 was used as a tag to demonstrate
and characterize progestin binding in adipose tissues (see Chapter IV)
and its binding efficacy relative to those of natural progestins, was
determined. A second goal of these studies was to compare the
behavioral and metabolic effects of the two progestins, progesterone
and R5020, for later comparison with the parallel adipose tissue
binding data.
11
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General Methods
Anlinals.. Virgin female CD strain (Charles River Breeding Laboratories)
rats, weighing approximately 200 g at the start of the experiment, were
housed individually in hanging wire-mesh cases (Wahman) and were
maintained on a 12 h light: 12 h dark cycle. Purina laboratory chow
pellets and tap water were available ad libitum throughout the
experiment.
Animals were ovariectomized via bilateral, dorsolateral
incisions under methoxyflurane (Metofane, Pitman-Moore) anesthesia.
Care was taken to remove as little non-ovarian tissue as was possible,
and to cause minimal disturbance to the parametrial adipose depot.
Body weight and food intake measurements
. Approximately two weeks
following surgery, food intake and body weight measurements began.
Food intake, adjusted for spillage, was measured to the nearest
0.1 g while body weights were determined to the nearest g. Measure-
ments were made either twice a week (Monday and Friday) or every
three days.
After three or four baseline points were gathered, animals
were grouped as necessary for the particular experiment, with groups
being matched for mean body weight and food intake over the baseline
period.
During the subsequent time period (2-3 weeks), hormones were
administered and body weight and food intake measurements continued as
were described for the baseline period. At the end of the experi-
mental period, rats were given an overdose of sodium pentobarbitol
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(Nembutal) and analyzed either for carcass composition (Experiment I or
II) or for adipose cellularity (Experiment III).
u^' U/''!.' '^^Q^Q progesterone on FoodIntake, Body Weight and Carcass Composition in~mrR^—
Methods. After being matched for body weight and food intake, rats
were given daily injections of either oil (n=8), 100 ug R5020 (n=8) or
2 mg progesterone (n=8). Following two weeks of progestin treatment,
animals were sacrificed.
Carcass analyses were performed according to a modification of
the method of Leshner, Litwin and Squibb (1972). Rats were shaved and
eviscerated, and then dried at 70-80 C to a constant weight in order to
determine total carcass water content. Dehydrated carcasses were then
ground in a Waring blender, and a homogeneous sample (approximately
.5g) was taken for further analyses. Lipid was extracted with 2 x 10 ml
petroleum ether; and protein was extracted from the delipidated sample
with 0.3N KOH. Water and lipid content were determined by weight
differences, while protein was determined by the method of Lowry et^ al_.
(1951).
Results
.
There were no differences in food intake as a result of
administration of either progesterone or R5020 to OVX rats. Similarly,
as summarized in Table I, there were no progestin-induced effects on
body weight or carcass composition in these rats.
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TABLE 1
THE EFFECTS OF PROGESTERONE OR R5020 ADMINISTRATION ON
BODY WEIGHT AND CARCASS COMPOSITION IN OVX RATS
(Mean + S.E.M.)
BODY WEIGHT
GROUP INITIAL FINAL
OIL 296 324
(n=8) +6 +8
PROG. 295 315
(n=8) +6 +6
R5020 296 324
(n=3) +4 +6
CARCASS ANALYSIS:
PERCENT WET WEIGHT
WATER LIPID PROTEIN
59.2 15.6 14.2
+1.7 +2.0 +0.6
60.4 15.4 14.1
+1.2 +1.1 +0.7
60.7 13.0 14.0
+0.9 +0.7 +1.1
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u!'!!!Kr'"!!.'1^.
^ ^.^^" ^ ^ '^^Q^Q Progesterone on Rndv
weight and Carcass Composition in Estrogen-primed OVTRitt
Methods. Two weeks following OVX, baseline body weight measurements
began, with body weight data being collected twice weekly throughout
the experiment. After three data points per animal had been collected,
40 OVX animals were divided into 4 matched groups of 10 animals each.
Rats received daily injections for the next three weeks of either oil,
2 ug E2B, 2 ug plus 2 mg progesterone, or 2 ug E2B plus 100 ug
R5020.
In addition, a group of oil -injected, gonadal ly-intact females
was weighed every three days throughout the experiment. These
animals were the same age as were the surgically treated animals.
At the end of three weeks of hormone or vehicle administration,
rats were sacrificed and carcass analyses were performed as described
in Experiment I.
Results
. Analysis of the final body weights for the hormone treated
OVX rats revealed a significant treatment effect (F^ 25=3.84; £ < .02).
Post hoc comparisons of means, using a Newman-Keuls test, revealed a
significant (p. < .05) decrease in body weight in E2B-treated animals
relative to oil injected controls (Table 2) and a significant
(p^ < .05) reversal of this estrogen-induced supression of body weight
by a concurrent treatment with R5020 (100 ug per day). Although daily
injections of 2 mg progesterone partially reversed the E2B-induced
suppression in body weight, the effect was not statistically
significant.
Carcass analyses revealed that the only component of the carcass
which had a significant change in the percent of total (wet;
^3,36^^''^^'' P ^ -Q^^ ^^3,36"^-''^' P -^2) carcass following
hormone manipulation was that of the lipid. treatment decreased
total carcass fat content, while concurrent R5020 administration in-
creased total lipid to control (OVX) levels (Table 2). This same
change in lipid content was reflected in the percent of the dehydrated
body which was lipid (Table 2). No differences were observed in
either water content or total protein content as a result of hormone
administration to OVX rats.
Gonadal ly intact animals weighed less than did any of the OVX
animals, both at the beginning and at the termination of the hormone
administration. Ovariectomy (OVX-oil versus gonadally intact-oil)
resulted in a nonsignificant increase in total lipid content and a
decrease in carcass protein content (Table 2).
Experiment III. Effects of R5020 and Progesterone on Food Intake
,
Body Weight and Adipose Cellularity in Estrogen-primed OVX Rats
Methods
. Starting two weeks following OVX, baseline food intake and
body weight data were collected for 48 rats as described in Experiment
I. Animals were divided into four matched groups (n=10 each), and
for the next 24 days received daily subcutaneous injections of either
oil, 2 ug EgB, 2 ug E2B plus 2 mg progesterone, or 2 ug E2B plus 100
ug R5020. Food intake and body weight measurements were taken every
three days throughout the hormone administration period.
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TABLE 2
THE EFFECT OF PROGESTERONE OR R5020 ADMINISTRATION ON BODY WFTRHT
AND CARCASS COMPOSITION IN OVX, E2B-TREATED RATS
GROUP
OVX:
OIL
(n=10)
OVX:
E2B
(n=10)
OVX:
E2B + PROG.
(n=9)
OVX:
E2B + R5020
(n=10)
BODY WEIGHT
CARCASS ANALYSIS
PERCENT WET WEIGHT
INITIAL FINAL WATER LIPID
CARCASS ANALYSIS
PERCENT DRY WEIGHT
PROTEIN LIPID PROTEIN
'
269
+ 5
272
+ 7
273
+ 6
272
+ 6
292*
+ 9
266
+ 7
280
+ 7
297*
+ 5
59.6
+1.1
61.1
+0.8
61.2
+0.8
60.3
+0.8
14.1
+0.7
11.7
+0.7
12.4
+0.7
14.1*
+0.7
14.1
+0.9
14.5
+1.1
15.2
+1.0
14.6
+0.9
34.9*
+1.7
30.4
+1.4
31.9
+1.2
35.4*
+1.3
34.8
+1.8
37.1
+2.7
39.4
+2.7
36.8
+2.3
3,36
NS
3.84
<.02 NS
3.25
<.05 NS
3.76
<.02 NS
INTACT: 223 239 59.7 13.2 15.7 32.5 37.8
OIL +4 +5 +0.9 +0.9 +0.7 +1.8 +1.5
*£ < .05 versus EgB
All data are presented as mean + S.E.M.
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An additional group of gonadal ly intact, oil injected female
rats was run, with similar food intake and body weight data being
collected as are described above. No attempt was made to monitor the
hormonal status of these animals at the time of sacrifice.
At the end of the 24-day treatment period, animals were sacrificed
and parametrial adipose depots were rapidly dissected and weighed.
Adipose cellularity was analyzed in parametrial fat pads according to
a slight modification of the photomicrographic method of Lavau et al.
(1977). Adipose cells were dispersed by collagenase (Worthington)
digestion, and 10 ul aliquots of the cell suspension were immediately
smeared on a slide and photographed through a microscope using a
yellow filter. Pictures of a standard micrometer were taken under
identical conditions for use as scales in the cell diameter size
determinations. To measure cell diameters, negatives of the photo-
micrographs were projected onto an electronic grid and diameters were
digitized using a Gar-Graf pen. Data were automatically stored and
analyzed by a Nova-3 computer, with calculations being made of the
mean cell diameter, volume and weight for at least 250 adipocytes per
fat depot.
Lipid extractions were done on pieces of adipose tissue from the
same depot as was used for the cellularity analysis. Preweighed
pieces of fat were homogenized in an hexane: isopropanol (3:2; vol/vol).
Na2S0^ was added; the samples were shaken vigorously; and the aqueous
phase was decanted. The organic phase was added to preweighed vials.
Lipid content was determined by drying the vials to a constant weight.
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Parametrial pads were chosen for these analyses because prior
studies (Wade and Gray, 1978) had demonstrated that the highest levels
of cytoplasmic estrogen receptor sites were found in this adipose
depot. Induction of progestin receptors, following E^B treatment, was
also highest in parametrial pads (see Chapter IV). Finally,
Steingrimsdottir, Brasel and Greenwood (1980) reported that the
greatest change in adipose cellularity and adipose tissue LPL activity
following progesterone treatment was found in the parametrial adipose
depot of gonadal ly intact rats. These data suggested that maximal
responsiveness to hormone administration would be found in the para-
metrial fat pad of OVX rats.
Results
.
During the first week of hormone treatment to OVX rats,
suppressed food intake by approximately 25% (Figure 1), while con-
current daily injections of either progesterone or R5020 attenuated
these effects of (F2^^=5.95; p < .002). Food intakes began to
return to normal, for all groups, during the second week of hormone
treatment and control values were found by the end of the experiment.
Changes in body weight paralleled the changes in food intake in
hormone- treated, OVX rats. Again E2B treatment suppressed body weight,
while concurrent progestin (R5020 or progesterone) treatment resulted
in increased body weights relative to the E^B-treated animals (Figure
2). Hormone induced changes in body weight were not statistically
significant in this experiment (F^ .,=2.01; £= 0.13).
Figure 1. Effects of progesterone
or R5020 on food intake in OVX, E2B-
treated rats.
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Figure 2. Effects of progesterone or
R5020 on body weight in OVX, E2B-treated rats.
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Adipose tissue cellularity data for the parametrial pad of these
animals are presented in Table 3. Although no significant (£ < .05)
differences were found for any measurement, analysis of variance for
the fat cell weights revealed a treatment effect approaching signifi-
^''3,36^ -0^8). Post-hoc analyses of adipose cell
weights revealed no significant differences, although comparisons
between oil and either or plus R5020 cells approached signifi.
cance ( .05 < £< .10).
TABLE 3
THE EFFECT OF PROGESTERONE OR R5020 ADMINISTRATION OR
PARAMETRIAL DEPOT CELLULARITY IN E2B-TREATED, OVX RATS
PARAMETRIAL FAT DEPOT
PAD WT. LIPID CELL WT. CELL NO.
GROUP INITIAL FINAL (g) (g) (ug) xlO-b
OVX: 293 324 5.11 3.97 1.49 5.29
OIL ± 9 +10 +0.56 + .50 + .34 +1.15
OVX: 293 288 4.67 3.86 0.69 7.19
E2B +10 +10 + .58 + .50 + .10 +1 .26
OVX: 293 296 5.01 4.01 1.18 5.25
E2B + ± 9 + 8 + .58 + .62 + .25 + .69
PROG.
OVX: 293 314 4.53 3.42 0.74 7.16
E2B + +10 + 9 + .59 + .44 + .10 +1.22
R5020
INTACT: 268 291 • 7.21 5.76 1 .43 7.34
OIL + 6 + 4 +1.07 + .96 + .49 +1.23
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Discussion
In the absence of estrogens, neither progesterone (5 mg per day)
nor R5020 (100 ug per day) had any effect on food intake, body
weight gain, or carcass composition. In E2B-treated animals, however,
both progestins increased food intake and body weight gain relative
to E2B-treated controls. R5020, at one- twentieth the dose of pro-
gesterone, was more effective than was progesterone in causing these
changes.
As was previously reported for progesterone (Galletti and Klopper,
1964; Hervey and Hervey, 1977) when concurrently administered with
E2B, R5020 caused a significant increase in the amount of carcass lipid,
both as a percent of wet (total) and dry carcass weights, when com-
pared to EgB-treated animals (Table 2). Across hormone treatment groups
there were no differences in the amount of carcass water or protein.
The effects of treatment with either E2B, E2B plus progesterone,
or E2B plus R5020 on adipose cellularity in the parametrial adipose
pad of OVX rats were studied. Although no significant results were
found, there was a strong trend toward a decrease in fat cell size
following E2B treatment, with concurrent progesterone treatment in-
creasing adipocyte size (Table 3). These data are in agreement with
previous reports (Salans, 1974; Steingrimsdottir, Brasel and Greenwood,
1980) using intact rats in which estrogen treatment decreased and
progesterone treatment increased fat cell size. As there were no
differences in fat cell number, the differences in fat cell size were
reflected in parallel changes in fat depot size.
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As compared with the data of Steingrimsdottir, Brasel and Green-
wood (1980), who used intact rats, progesterone treatment in OVX,
E2B-treated animals in these experiments had less of an effect on
parametrial fat pad size or cellularity. One possible factor is the
dose of progesterone used. Steingrimsdottir et al. gave daily in-
jections of 5 mg. progesterone, while I g^ve only 2 mg per day. Also
to be considered is the traumatic effect of ovariectomy on the
parametrial fat depot. Even with the most careful and conservative
surgical procedures, ovariectomy results in disruption of neuronal and
vascular connections to the uterine-parametrial area. The con-
sequences of these "inadvertant" post-surgical disruptures may include
a diminished responsiveness to hormonal treatment in the parametrial
fat depot.
Unlike progesterone, R5020 appeared to have no effect on para-
metrial fat pad or cell size in E2B-treated, OVX rats (Table 3).
However, R5020, like progesterone, did exert its weight enhancing
effects through an increase in carcass lipids.
CHAPTER III
INTERACTION OF AN "ANTIESTROGEN" AND PROGESTERONE IN AFFECTING
FOOD INTAKE, BODY WEIGHT, AND CARCASS COMPOSITION
Synthetic antiestrogens, including nafoxidine, antagonize the
effects of estradiol on a variety of measurements, including long-term
uterine growth, female sexual behavior, binding to estrogen receptors,
maximal induction of progestin receptors, and serum hypertriglyceri-
demia (Chan et al., 1976; Gerall, Napoli and Cooper, 1973; Komisaruk
and Beyer, 1972; Lerner, 1964; Pageaux, et al. , 1980; Roy, MacLusky
and McEwen, 1979; Roy and Wade, 1975; Walker and Feder, 1977). How-
ever, both nafoxidine and MER-25 have been shown to be estrogen-
like in their suppression of food intake (Roy and Wade, 1976; Wade and
Blaustein, 1978).
The following experiment was designed to further explore some of
the estradiol-agonistic and antagonistic effects of nafoxidine and to
look at the effects of concurrent progesterone and nafoxidine treatment
on food intake, body weight gain, carcass composition, serum trigly-
cerides and uterine weights. These data were compared to parallel
findings from animals treated either with E2B or E^B plus progesterone.
General Methods
Animal
s
. Sixty female rats were ovariectomized and maintained as
described in Chapter II,
Experimental measures . Body weight and food intake measurements were
made twice a week as described in Chapter II.
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Experiment IV Concurrent Administration of N.foviH.-no with
_EpB_or Progesterone: Effects on Food I ntake, body Weight "
Carcass Composition and Plasma Triglyceride?
—
—
'
Methods. Following baseline body weight and food intake measurements,
rats were divided into six matched groups (n=10, each) and given daily
injections of either oil, £38 (2 ug), nafoxidine (2 mg), E2B plus
nafoxidine, E^B, plus progesterone (5 mg), or nafoxidine plus progest-
erone. Food intake and body weight measurements continued throughout
the experiment.
At sacrifice, one animal in the EgB plus progesterone group was
found to be gonadally intact; all data from this animal were discarded
in the analysis.
After three weeks of hormone administration, rats were given an
overdose of Nembutal, and 2 ml of blood was taken by cardiac puncture
into heparinized syringes. The blood was chilled and centrifuged, with
plasma being saved for later analysis of glycerol and triglyceride
2
levels
.
Uteri were carefully dissected and weighed. They were then
dried overnight at 70 C and reweighed. Carcasses were prepared for
analysis as described in Chapter II, except that a food processor
(Hamilton Beach) was used in addition to the blender in the carcass
grinding steps.
Results . Hormone administration resulted in significant changes in
both food intake (day 1-7 of hormone treatment, F^ ^^=9.33\ £ < .0001;
day 1-21 of hormone treatment, F^ ^y6A2; £ < .001) and body weight
(final day of hormone treatment, F^ ^^=6.0^\ £ < .01). As was
expected, E2B treatment (2 ug/day) decreased food intake (Figure 3,
Figure 3. Effects of E^B, nafoxidine
and progesterone, alone and in Combination,
on food intake in OVX rats.
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Table 4) and body weight gain (Figure 4, Table 4) in OVX animals,
while concurrent progesterone (5 mg/day) administration attenuated
these effects.
Nafoxidine (2 mg/day), alone and in combination with E2B, had
very similar weight reducing effects as did E2B, while the depression
of food intake following nafoxidine treatment was more prolonged than
was the anorexia following treatment with E^B alone (Figures 3 and 4).
Progesterone treatment also significantly attenuated the food intake
and body weight suppressant effects of nafoxidine (Figures 3 and 4,
Table 4).
Differences in uterine weights were found with both wet
(^5^53=38. 70; £ < .0001) and dry (F^ ^^=28.5]; £ < .0001) tissues
(Table 4). All hormone treatments induce both wet and dry uterine
weight increases (^'s all < .05), relative to oil treatment. E2B
induced significantly higher (£'s < .0 1 versus all other treatments)
uterine weights, both wet and dry, than did any other treatment. Con-
current administration of nafoxidine blocked the magnified E2B-induced
uterine responses (Table 4). While progesterone significantly
affected (£'s < .01) uterine wet and dry weights in E2B treated
animals, it had no effect on uterine weights in nafoxidine-treated
rats (Table 4).
Although there were no differences in plasma glycerol levels
across hormone treatment groups, plasma triglycerides did vary
significantly as a function of hormone treatment (F^ ^^=^3.2Q;
£ < .01; Table 5). Both E2B alone and E2B plus progesterone treat-
ments resulted in significant (£ < .005) increases in triglyceride
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TABLE 4
EFFECTS OF £38, NAFOXIDINE AND PROGESTERONE, ALONE AND IN COMBINATION,
ON BODY WEIGHT, FOOD INTAKE. AND UTERINE WEIGHTS IN OVX RATS
GROUP
BODY WEIGHT FOOD INTAKE (q) UTERINE WEIGHT (mq)
INITIAL FINAL PIAVn 1 7Un 10 1 -
/
WET DRY
OIL 318.1
+ 4.7
335.8
+ 9.0
156.4^
+ 4.3
449.3^
+13.3
161.12^
+19.40
38.85^
+ 2.51
E«B 318.0
+ 5.1
292.1^
+ 4.8
115.5^'^
+ 4.8
371.2^
+17.4
564.22^
+38.43
2
114 12
+ 6.58
NAFOXIDINE 318.4
+ 4.1
296 n
+ 6.8
117.3^'"^
+ 4.4
351.3^
+11.4 +15.33
60.51
+ 7.34
I- 0 U ' "^1 7 1
2
PQ/I Q'- 113.7^ 344.3^ 238.97 59.94^
NAFOXIDINE + 4.6 + 7.2 + 4.6 +12.4 +17.79 + 2.45
E2B + 325.0 324.8^ 129.6^ 392.9^ 410.74^ 88.41^
PROGESTERONE + 5.2 + 6.9 + 6.8 +15.0 +28.92 + 3.98
NAFOXIDINE +
PROGESTERONE
317.4
+ 4.4
325.2^
+10.6
2 3
126.8
+ 6.2
386.3^
+18.7
296.78^
+32.16
4
68.69
+ 4.31
^5,53 6.04 9.33 6.42 38.70 28.51
NS <.001 <.0001 <.001 <.0001 <.0001
Data with the same superscripts are not significantly (< .05) different
from each other.
All data are presented as, mean S.E.M.
Figure 4. Effects of E^B, nafoxidine
and progesterone, alone and in combination,
on body weight in OVX rats.
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levels, with concurrent progesterone treatment significantly adding
to the estrogen-induced hypertriglyceridemia (Table 5).
Carcass analysis (Table 6) revealed significant treatment effects
in both water (F2^27=^.69; £ < .01) and lipid
^^^f^.'^^', £ < .01)
content when oil, nafoxidine and nafoxidine plus progesterone animals
were compared. Post hoc analysis revealed significant decreases in
carcass lipid and increases in carcass water content following
nafoxidine treatment. Relatively large variances precluded statistical-
ly significant differences from being found between nafoxidine and
nafoxidine plus progesterone groups. Further analysis, however, shows
more dramatically the lipogenic effects of progesterone following
nafoxidine treatment. If total carcass lipid is presented in grams,
rather than as a percent of body weight, it becomes more apparent that
a major portion (28%) of the difference between the nafoxidine and
the nafoxidine plus progesterone-treated animals is in fat content
(Table 6).
Discussion
Nafoxidine was "antiestrogenic" with regard to uterine growth
(both wet and dry uterine weights) in these animals. However, like
E2B, nafoxidine treatment decreased food intake and body weight gain
(Figures 3 and 4). These data support those previously reported
which indicate that nafoxidine (Wade and Blaustein, 1978) as well as
other so-called antiestrogens (Poteat, 1977; Roy and Wade, 1976) are
estrogen-like in their suppression of food intake and body weight
regulation.
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TABLE 5
EFFECT OF E.B, NAFOXIDINE AND PROGESTERONE, ALONE AND IN COMBINATION
ON ^ERUM GLYCEROL AND TRIGLYCERIDE LEVELS IN OVX
^^^^^^^^^^^
,
GROUP GLYCEROL TRIGLYCERIDES
TmoTM) (umoi/ml)
OIL
.134 735I
+.015 +.124
.123 1.026^
+.019 +.230
NAFOXIDINE
.124 552^
+.015 +.104
E2B + NAFOXIDINE .073 .336^
±.013 +.059
EpB + PROGESTERONE .108 1.890^
+
. 01 0 +
. 288
NAFOXIDINE + .107 .552-^
PROGESTERONE +.022 +.104
^5,53 1.76 13.283
p NS <.005
Data points with the same superscript in the triglycerides column
are not significantly (£ < .05) different from each other.
TABLE 6
EFFECTS OF NAFOXIDINE AND PROGESTERONE ON CARCASS COMPOSITION
IN OVX RATS
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GROUP
CARCASS COMPOSITION
PERCENT WET WEIGHT
WATER LIPID PROTEIN
TOTAL LIPID
OIL 62.0
+0.7
14.7
+1.1
13.5
+0.3
44.6
+4.0
NAFOXIDINE 65.5
+0.6
9.8
+0.9
13.7
+0.4
26.0
+2.5
NAFOXIDINE + 64.4 11.6 13.3
PROGESTERONE +0.7 +1.1 +0.4
34.2
+3.9
'2,27 6.69 5.94
<.01 <.01 NS
6.88
<.01
All data are presented as means + S.E.M.
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The return of food intake toward control values appears to be
slower in nafoxidine than treated animals (Figure 3). Wade and
Blaustein (1978) found that a single injection of nafoxidine (4 mg)
caused food intake to be depressed by at least 30% for 6 days, much
longer than would be expected with E^B treatment alone.
As had been previously shown with E2B (Chapter II), nafoxidine
decreased carcass lipid content in OVX rats. Concurrent progesterone
treatment partially reversed this estrogen-like effect on total
carcass fat content (Table 6). These results were found despite the
fact that nafoxidine, either alone or in combination with progesterone,
did not induce serum hypertriglyceridemia as was found following
either E2B or E2B plus progesterone treatment (Table 5). These serum
triglyceride data support those previously reported by Chan et al_.
,
(1975) in which nafoxidine was shown to inhibit estrogen induced
hypertriglyceridemia in birds. These data also show that levels of
serum triglycerides, £er se_, can not be the only important factor in
regulating food intake and body weight gain following hormone
manipulation.
CHAPTER IV
CHARACTERIZATION OF CYTOPLASMIC PROGESTIN BINDING
IN ADIPOSE TISSUES OF OVX-ADX RATS
The studies which were reported in Chapter II, as well as those
which have been reported by other authors (Galletti and Klopper, 1964;
Hervey and Hervey, 1967; Leshner and Collier, 1973), demonstrate that
the major change in carcass composition following hormone treatment is
found in the total carcass fat content. We have suggested (Wade and
Gray, 1979) that hormones might be having direct effects on peripheral
metabolic tissues such as adipose tissues. In support of this
hypothesis, we have demonstrated the presence of high affinity,
estrogen specific, macromolecular binding sites for 17B-estradiol
in the cytoplasm of adipose tissues from OVX rats (Wade and Gray, 1978),
In agreement with the current dogma of the mechanism of action for
steroid hormones, we also demonstrated specific in vivo nuclear
accumulation of radioactivity in adipose tissues after injection of
3
( H)173-estradiol (Gray, Dudley and Wade, 1980).
The purpose of the following series of studies was to demonstrate
and to characterize cytoplasmic progestin binding in adipose tissues
of OVX-ADX rats. One explanation for a lack of progestin-induced
metabolic or behavioral response in the absence of estrogens is
that estrogens are necessary for the induction of cytoplasmic progestin
receptors. Therefore, in addition to studying the affinity and the
specificity of these progestin binding sites, I examined the induction
of these binding sites under different estrogen (E2B) priming
conditions.
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R5020, the synthetic progestin used in the food intake and adi-
posity studies reported in preceding chapters, has been used to
demonstrate specific progestin binding sites in the uterus, vagina,
pituitary, and brain (Blaustein and Feder, 1979; Leavitt et al., 1977;
MacLusky and McEwen, 1978; Raynaud, 1977). R5020 binds tightly to the
progestin receptor, with an association constant approximately four
times that of the natural progestin, progesterone (Philibert and
Raynaud, 1974). Since R5020 has been used successfully in describing
progestin binding sites in other tissues, I chose to use this compound
in examining progestin binding in the cytoplasm of adipose tissues.
General Methods
Animals
.
Multiparous CD strain rats (Charles River Breeding
Laboratories), weighing 350-450 g were housed 7-9 per cage and were
maintained under a 12 h light: 12 h dark cycle. Animals were
ovariectomized and adrenal ectomi zed (ADX) via bilateral dorsolateral
incisions under methoxyflurane (Metofane; Pitman Moore) anesthesia.
They were maintained on Purina Rodent chow and 0.9% saline ad libitum .
Tissue preparation
.
Adipose tissues were dissected, as previously
described (Wade and Gray, 1978), and homogenized in ground-glass
tissue grinders (Duall size 23; Kontes) at a concentration of 400 mg
tissue per ml buffer containing lOmM Tris-HCl, 1.5 mM EDTA, 12 mM
monothioglycerol , and 10% (vol/vol) glycerol, pH. 7.4 (TEMG). This
and all subsequent steps were performed at 4 C. Homogenates were
centrifuged at 48,000 x £ for 30 minutes.
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Assay conditions
.
Cytoplasmic progestin binding in adipose tissue was
assayed according to the method of MacLusky and McEwen (1978) as
modified by Blaustein and Feder (1979). Aliquots (250 ul) of the high
speed supernatant were incubated with (3h)R5020 (New England Nuclear)
for 4 hours at 0 C with or without the addition of various competitors
or enzymes. Bound and free (^H)R5020 were separated by gel filtration
on 5 X 60 mm. Sephadex LH-20 columns, equilibrated with TEMG, as
described by Ginsburg et al. (1974) but using TEMG as the eluent. Two
hundred microliters of the incubate were pipetted into the column and
washed in with 200 ul TEMG. Thirty minutes later, the protein peak was
eluted into a scintillation vial with 800 ul TEMG, and 12 ml toluene-
based scintillation fluid were added. Samples were vigorously shaken
and counted to a standard deviation of less than M in a Packard model
2425 liquid scintilation spectrometer at an efficiency of 55+1%.
To determine the protein concentrations of the cytoplasmic
fractions, 100 ul aliquots of the high speed supernatants were pre-
cipitated with 5 ml ethanol. The precipitate was dried, dissolved in
0.3 N KOH, and assayed for protein by the method of Lowry et aj[.
(1951). Because significant amounts of the R5020 seemed to be
absorbed to either plastic or glass incubation tubes, the total (bound
plus free) ( H)R5020 concentration of the incubates was determined by
counting 20 ul aliquots at the end of the incubation period.
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Experiment V. Saturation fln.iwc.. of (^H)R5n?n RinH.-n,in Cytoplasm of Par.mo.
.liTi5fH^~4i^^
Methods. Saturation analyses were conducted on high speed super-
natans of parametria! fat pads from unprimed OVX-ADX rats or from
OVX-ADX rats which had been primed with 2 ug E.B per day for 7 days.
Pooled (within priming condition) high speed supernatant was incubated
with increasing concentrations (0.05 - 4.0 nM) of (3h)R5020 in the
presence or absence of 1 uM unlabel led R5020. Scatchard analyses
(Scatchard, 1949) of the specifically bound fractions were performed
and dissociation constants (K^'s) were calculated.
Results. Only very low levels of (3h)R5020 binding were measurable in
the cytoplasmic fractions of parametria! pads from untreated OVX-ADX
rats (data not shown). Priming with induced a substantial
quantity of cytoplasmic progestin binding sites (Figure 5). Scatchard
analysis of the specifically bound (^H)R5020 yielded a of 8.5 x
10 (Figure 5) in E2B-primed rats.
Experiment VI. In Vitro Specificity of (^H)R5Q20
Binding in Cytoplasmic Fractions of Parametria! Adipose Tissue
Methods
.
To determine the specificity of ('^H)R5020 binding in the
cytoplasm of parametria! adipose tissue from estrogen-primed, OVX-ADX
rats, high speed supernatant from pooled parametria! fat pads of rats
pretreated for 3 days with 2 ug E2B were incubated with 2nM (^H)R5020
with either no competitor or with 20, 200, or 2000 nM R5020, proges-
terone, 5a-dihydroprogesterone, 5a-dihydrotestosterone, estradiol, or
corticosterone. Duplicates were run for each concentration of
Figure 5. Saturation and Scatchard
plots of (3h)R5020 binding in cytoplasm of
parametrial adipose tissues from E?B-treated,
OVX-ADX rats.
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competitor.
Results. Unlabelled R5020 was approximately 8 times more effective in
competing for binding sites than was progesterone, which in turn was
about 8 times as effective as the progesterone metabolite, 5a-dihydro-
progesterone (Figure 6). All three progestins tested were more potent
inhibitors than were 173-.estradiol
, 5a-dihydrotestosterone, or
corticosterone (Figure 6).
Experiment VII. Regional Differences in ('^H)R5Q20
Binding in Adipose Tissues
Methods. Regional differences in the binding of progestins was
measured in the cytoplasms of parametrial, retroperitoneal, omental,
inguinal and interscapular brown fat of E2B-primed (2 ug E2B/day for
3 days) or unprimed rats. Specific progestin binding in this experi-
ment, and in all further experiments, was determined by incubating the
high speed supernatant with 2nM (^H)R5020 in the presence or absence
of O.SuM unlabelled R5020.
Results
.
Very low levels of progestin binding were observed in high
speed supernatants from the various pads of unprimed animals (Figure
7). Daily E2B induced additional progestin binding sites in all
adipose tissues studied. The greatest induction (26-fold) was found
in parametrial pads, followed by inguinal, retroperitoneal, omental
and brown fat (Figure 7); the differences in estrogen-priming across
fat pads were highly significant (F^ ^q=34.9; £ < .001). We have
previously reported (Wade and Gray, 1978) significant regional
Figure 6. In vitro specificity of
(3h)R5020 binding in cytoplasm of parametrial
adipose tissues in E2B-treated, OVX-ADX rats.
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Figure 7. Regional differences in bindi
of (3h)R5020 in cytoplasm of various adipose
depots in E;,B-primed, OVX-ADX rats.
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differences in 17B-estradiol binding in adipose tissues (parametria! >
retroperitoneal > brown > omental > inguinal ) . Further analyses of these
binding data show that, given the basal (unprimed) level of progestin
receptors and the concentration of estrogen receptors in a specific pad
(Table 7), the absolute level of induced (from E2B-primed animals)
progestin receptors can be predicted by multiple linear regression
(R=.998, F2^^=204.0; £ <.0001). Significant predictions can also be
made from these data of the magnitude of induction of progestin
binding sites (induced level/basal level; R=.990, ,=47.5, p <.002).
There is also a highly significant correlation between fat pad
estrogen receptor concentration and magnitude of progestin receptor
induction (induced progestin receptor/basal progestin receptor;
r=.96, t 3=5.87, £ < .01).
Experiment VIII. Time Course of Induction of ('^H)R5020
Binding in Adipose Tissues Following a Singl e Pulse of
—
^
Methods
.
The time course of induction of progestin binding after
administration was determined by assaying (^H)R5020 binding in high
speed supernatant from parametria! fat pads of animals which are
sacrificed 0, 6, 12, 24, 36, 48, or 60 hours after a single injection
of 2 ug E2B.
Resul ts . Although no significant induction of progestin binding was
observed 6 hours after injection of E2B, cytoplasmic binding rose
rapidly between 6 and 12 hours post-injection (Figure 8). Peak binding
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Figure 8. Time course of induction of
parametrial cytoplasmic binding sites for
(3h)R5020 following E^B administration to
OVX-ADX rats.
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was observed between 12 and 36 hours, and binding diminished to about
25% of maximal levels of 60 hours (Figure 8).
Experiment IX. jn Vivo Depletion of Cytoplasmi c Progestin
Binding in Adipose Tissues
'
Methods. To determine the relative potencies of various progestins
in depleting available cytoplasmic progestin receptors in vivo,
cytoplasmic (2h)R5020 binding was determined one hour following in-
jection of vehicle (.1 cc EtOH), 500 ug progesterone, 500 ug un-
label led R5020, or 500 ug 5a-di hydroprogesterone.
^^s^l^s. Following treatment with three progestins, a significant
treatment effect was found in the effect on the depletion of cytoplasmic
progestin binding inparametrial adipose tissues (F3 q=12.92; £ <.01).
The order of efficacy of depletion was R5020 > progesterone > 5a-
dihydroprogesterone (Figure 9).
3 Experiment X. Effects of Hydrolytic Enzymes on
( H)R5020 Binding in Cytoplasm of Parametria! Adipose Tissues
Methods
.
The effects of various hydrolytic enzymes were determined by
measuring the binding of (^H)R5020 in pooled high speed supernatant
from parametria! fat pads of E2B-primed animals incubated with RNase
(0.5 mg/ml ; bovine pancreas; Worthington) , DNase (0.5 mg/ml ; bovine
pancreas/Worthington)
,
pronase (0.5 mg/ml; Sigma), or no enzyme. All
conditions were run in duplicate.
- Figure 9. Ijn vivo
(•^H)R5020 binding sites
of different progestins
depletion of parametria!
following administration
to OVX-ADX rats.
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Resulis. Incubation of cytoplasmic fractions from parametria! adipose
tissues with either DNase or RNase had no effect on (^H)R5020 binding.
Pronase, on the other hand, caused a 95% inhibition of specific
progestin binding (Figure 10).
Discussion
The ( H)R5020 binding to high speed supernatant from adipose
tissues of OVX-ADX rats is comparable to progestin binding previously
reported in other tissues (Blaustein and Feder, 1979; Leavitt et al_.
,
1977; MacLusky and McEwen, 1978; Raynaud, 1977). The binding is of high
affinity, with a calculated of 8.5 x 10'^ ^M. Specificity was
demonstrated, with the progestins R5020, progesterone and 5a-
dehydroprogesterone being more effective competitors for binding sites
than were an estrogen, an androgen or a corticosteroid. The nearly
total inhibition of binding in the presence of pronase and the lack of
effect of either RNase or DNase on progestin binding indicate that
the binding macromolecule is probably a protein.
Only very low levels of ( H)R5020 binding were found in adipose
tissues from animals which had not been previously treated with E2B.
Following estrogen priming, a significant induction of progestin
binding sites was observed in all adipose tissues studied. The
effects of the progestins^ progesterone and R5020, on food intake, body
weight and adiposity are not observed in animals lacking estrogens,
although they are seen in gonadal ly-intact and estrogen-primed, OVX
rats (Chapter II; Wade, 1976). This lack of a progestin effect in
the absence of estrogens could therefore be due to the absence of
Figure 10. Effect of hydrolytic enzymes
on parametria! cytoplasmic (3h)R5020 binding
in E^B-primed, OVX-ADX rats.
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progestin receptors in target tissues. Estrogens have been demon-
strated to induce progestin receptor formation in other progestin
sensitive tissues, such as hypothalamus, pituitary, uterus and vagina
(Blaustein and Feder, 1979; Leavi tt et al. , 1977; Leavitt et al.
,
1978; MacLusky and McEwen, 1978; Raynaud, 1977).
Regional differences have been found for absolute levels of
estrogen (Wade and Gray, 1978), basal (unprimed) and induced (E2B-
primed) progestin receptor, as well as in the magnitude of induction
of progestin receptors (induced binding/basal binding) in adipose
tissues. Regression analyses of these data indicate that the magni-
tude of the induction of progestin receptors is directly related to
the tissue estrogen receptor concentration and basal levels of
progestin receptor. This highly significant correlation between
estrogen receptor levels and a physiological response in adipose
tissue supports the contention (Wade and Gray, 1978, 1979) that adipose
tissues are bona fide target organs for estrogens.
In vivo depletion of available cytoplasmic progestin receptors
by R5020, progesterone and 5a-dihydroprogesterone was directly
related to their effectiveness in competing for cytoplasmic progestin
binding sites in vitro (R5020 > progesterone > 5a-dihydroprogesterone)
.
Efficacy in depleting cytoplasmic binding sites is also directly
related to the in vivo effects on body weight. R5020 is more effective
than progesterone (Chapter II), and progesterone is more effective
than 5a-dihydroprogesterone (Wade, 1975) in increasing food intake
and body weight gain in E2B primed rats.
CHAPTER V
THE EFFECTS OF PROGESTINS ON ADIPOSE TISSIIF I Pi flrTTwirv
IN VARIOUS FAT DEPOTS IN OVX, E^B-TREATED RA^S
In the absence of estrogens, neither progesterone nor R5020 has
any effect on food intake, body weight or body composition (Experiment
I; Hervey and Hervey, 1966; 1967). However these two progestins
effectively increase food intake and body weight gain in E2B-treated.
OVX rats (Experiments II and III; Hervey and Hervey, 1967; Roberts,
Kenney and Mook, 1972). Carcass analysis revealed that the major body
constituent which was affected by progestin treatment was body fat
(Experiment II; Galletti and Klopper, 1964; Leshner and Collier, 1973).
Lipoprotein lipase (LPL) is the enzyme involved in triglyceride
transport into adipose tissues. Previous studies have shown that
estrogen treatment decreases, and concurrent progesterone treatment
increases, adipose tissue LPL activity (Hamosh and Hamosh, 1975;
Kim and Kalkoff, 1975; 1978; Steingrimsdottir, Brasel and Greenwood,
1980). Steingrimsdottir and colleagues (Steingrimsdottir, Brasel and
Greenwood, 1980) have also shown that progesterone exerts its great-
est effect on LPL activity in parametrial depots, followed by
retroperitoneal and omental tissues. In all of the above studies,
hormones were administered to gonadal ly intact rats.
In the previous chapter, the presence of progestin binding sites
in several adipose depots of OVX, E2B-primed rats was demonstrated.
R5020 was shown to be a more potent competitor (i_.e^. competed for
binding at lower concentrations) for the progestin binding sites in
fat tissues.
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The following experiment was designed to study the effects of
the two progestins, progesterone and R5020, on adipose tissue LPL
activity in three different fat depots from OVX, E.B-treated rats.
The study addresses three points: a) Do progestins affect adipose
tissue LPL activity in OVX, E^B-primed rats (as opposed to gonadally
intact animals), b) does R5020 affect the activity of the enzyme in
the same manner as does progesterone, and at a dose which is signifi-
cantly less than the effective dose of progesterone, and c) are there
regional differences in changes in LPL activity following progestin
administration, and if so, do these differences reflect regional
differences in cytoplasmic progestin receptors?
Experiment XI. Effect of Progesterone or R502Q on LPL Activity
of Parametrial, Retroperitoneal and Inguinal Adipose Depots of
OVX, E2B-primed Rats
Methods
.
Four days after ovariectomy, 15 female rats were divided into
3 equal groups and began receiving injections of either E2B (2 ug),
E2B plus progesterone (5 mg) or E2B plus R5020 (200 ug). Daily
injections continued for 3 days. On the day after the last injection,
animals were sacrificed by decapitation and inguinal, parametrial and
retroperitoneal adipose depots were dissected and chilled on ice.
Lipoprotein lipase activity was assayed according to a modifica-
tion (Hietanen and Greenwood, 1977) of the method of Schotz et al
.
,
(1970). Tissues were homogenized at a concentration of 200 mg per
ml medium containing 0.25M sucrose and ImM EDTA, pH 7.4. Post-
mi tochondrial supernatants were incubated with a substrate emulsion
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containing (carboxyl^^) triolein (S.A. 84.1 mCi/mmol; Mew England
Nuclear), radioinert triolein, lysolecithin, fasted human serum,
fatty acid poor bovine serum albumin, and Tris-HCl buffer, pH 7.4.
Nonspecific hydrolase activity was assayed by adding NaCl to the
incubation tubes to inhibit LPL activity. The reaction was stopped
by addition of a chloroformrmethanol
: heptane (2.3:2.5:1 .8;v/v/v)
mixture. Phase separation was facilitated by addition of carbonate
buffer, pH 10.5. Samples were centrifuged and aliquots of the upper
phase containing free fatty acids (FFA) were pipetted into scintil-
lation vials; toluene based scintillation fluid containing 33% Triton
X-114 was added; and samples were counted at an efficiency of 85%.
Protein concentration were analyzed in aliquots of the post-
mitchondrial supernatants by the method of Lowry et al_. (1951) and
data are presented as umol FFA released/hr/mg protein.
Results
.
Three days of administration of either progesterone (5 mg)
or R5020 (200 ug) elevated adipose tissue activity in inguinal, para-
metrial, and retroperitoneal fat depots of E^B-primed, OVX rats
(Table 8). However, the only statistically significant difference
was found in the parametrial adipose depots of animals treated with
R5020 (£=.05; vx. E2B plus R5020; t-test).
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TABLE 8
THE EFFECT OF PROGESTERQNF OR R5020 ON LP! AfTTVTTY tw tmpiitma.
HORMONE
RATS
LPL Activity (umol FFA rpleased/hr/mq prnt.Pin^
FAT DEPOT
^^^^^'^^^'^ INGUINAL PARAMETRIAL RETROPERITONEAL
^2^
-038 .080
.065
±.009 +.013 +.011
+ PROGESTERONE
.073
.137 154
+.026 +.036 +.044
E2B + R5020
.061 .140* 105
±.011 +.020 +.045
*£ = .05, vx. E2B, two-failed jt- test
All data are presented as mean + S.E.M.
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Discussion
Statistical significance was only found in parametrial pads of
R5020-treated animals, although group means were elevated for all
adipose depots from animals treated with either R5020 or progesterone,
as compared with depots from animals treated only with (Table 8).
Other experiments (e.£. Gray and Wade, 1980; Steingrimsdottir, Brasel
and Greenwood, 1980; see also Experiment 14) have demonstrated
significant elevations in parametrial adipose tissue LPL activity
following progesterone administration to either intact rats or to
OVX animals treated with E2B. The exact reasons for the inability to
replicate these results in this experiment are unclear; further
investigation of relevant experimental factors are required.
Following progestin administration, Steingrimsdottir, Brasel and
Greenwood (1980) have shown that, in gonadal ly intact animals, pro-
gesterone treatment affects parametrial, but not retroperitoneal or
omental, tissue LPL activity. No test was made of inguinal tissue
LPL activity, although inguinal pads had the second highest amount
of progestin binding sites in adipose tissues (Experiment VII). That
the largest effect on enzyme activity is found in parametrial tissue
(above and Steingrimsdottir, Brasel and Greenwood, 1980) indicates
that there is a parallel between the amount of progestin binding sites
and physiological responsivity to progestin administration. Such a
parallel between adipose tissue hormone receptor levels and cellular
response level was shown, in Experiment VII for estrogen-induced
synthesis of progestin receptors and estrogen receptor levels.
CHAPTER VI
PROGESTINS AND ANTIESTROGENS
: THEIR EFFECTS ON ADTPOSE TISSUE
(^H)R502Q BINDING AND LPL ACTIVITY
The results of Chapter III indicate that the so-called anti-
estrogen, nafoxidine, is estrogen-like in its suppression of food in-
take and body weight gain. Similar results have been reported
previously for both nafoxidine (Wade and Blaustein, 1978) and for
another antiestrogen, MER-25 (Roy and Wade, 1976). Concurrent
progesterone treatment to animals treated with either MER-25 (Roy
and Wade, 1977) or nafoxidine (Chapter III) increased food intake and
body weight in a manner similar to that seen following progesterone
administration to estrogen-treated rats (Chapter III),
Carcass analysis revealed that, as with E2B-treated animals,
progesterone administration to nafoxidine-treated rats resulted in
an increase in total carcass fat content (Chapter III). These data
indicate that in animals which have been administered nafoxidine,
progesterone might act directly on adipose tissues to alter metabolic
processes.
Recent studies have demonstrated that synthetic antiestrogens,
including nafoxidine, can induce the synthesis of uterine and brain
cytoplasmic progestin receptors, although much less effectively
(approximately 50% induction) than is found with the true estrogens
{e.^. estradiol, E2B, estriol) (Jordan and Prestwich, 1978; Koseki
et al_. 1977; Leavitt et al. , 1977; Roy, MacLusky and McEwen, 1979).
In the previous series of experiments (Chapter IV), the presence of
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high affinity, E2B-induced cytoplasmic progestin binding in adipose
tissues was demonstrated. The following series of experiments was
designed to examine the effects of various synthetic antiestrogens,
especially nafoxidine, on the depletion of estrogen receptors and the
induction of progestin binding sites in the cytoplasm of parametrial
adipose tissues (Experiment XII).
In addition, I studied the effects on adipose tissue LPL activity
of antiestrogen treatment, with or without concurrent administration
of progesterone. I was interested to see whether or not antiestrogens
which mimic estradiol's anorexic actions (at least with regard to food
intake and body weight gains) had similar suppressant effects on
adipose tissue LPL activity (Experiment XIII). When decreases in LPL
activity were found following nafoxidine treatment, it was of interest
to see whether or not progesterone could reverse this effect in a
tissue with lowered amounts of progestin receptors (Experiment XIV).
General Methods
Animals . Female rats were housed and maintained as described in
previous chapters. Rats used in studies in which progestin binding
was assayed (Experiments XII & XIII) were both ovariectomized and
adrenal ectomi zed; when only LPL activity was assayed (Experiment XIV),
OVX rats were used.
Assays
.
Cytoplasmic progestin binding and LPL activity were determined
in parametrial adipose tissues as described in earlier chapters.
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In Experiment XII, cytoplasmic estrogen binding was determined
in the same fraction as was used for the progestin binding assay. To
determine estrogen binding, high speed supernatant was incubated at
24 C with 1 nM 176-(2H)estradiol (S.A. 115 Ci/mmol; New England
Nuclear) plus or minus 1 x lO'^M radioinert estradiol. Bound and free
( H)estradiol were separated by gel filtration as described on page
3 of Chapter IV, except that only 700 ul TEMG was used to elute the
protein fraction. Counting of radioactivity and analysis of the pro-
tein content were determined in the same manner as was described for
the progestin binding assay (Chapter IV).
Experiment XII. Antiestrogen Administration: Depletion
of Estrogen Binding and Induction of Progestin Binding in
the Cytoplasm of Parametrial Adipose Tissue
Methods
.
The depletion of cytoplasmic estrogen receptors and the
concurrent induction of cytoplasmic progestin receptors in parametrial
adipose depots were measured after a single injection of various
estrogens or antiestrogens. Animals were sacrificed 24 h after
injection of E2B (2 ug in sesame oil; n=6), estrone benzoate
(E^B; 2 ug in sesame oil; n=3), CI-628 (50 ug in saline; n=7),
nafoxidine (50 ug in saline, n=7) or MER-25 (500 ug in saline; n=7),
or no injection.
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Results
. Cytoplasmic ("^HjRBOZO and 176(^H)estradiol binding were
measured in parametria! fat depots after injection of various
estrogens and antiestrogens. (2 ug), CI-628 (50 ug), and nafoxi-
dine (50 ug) were effective in significantly depleting free cytoplasmic
estrogen receptors, while E^B (2 ug) and MER-25 (500 ug) were without
effect (Figure 11). Significant induction of progestin receptors
compared with control values were found following the administration
of E2B, CI-628, and nafoxidine (each £ < .01 by t_ test). Again, E-jB
and MER-25 were without effect.
Experiment XIII. Nafoxidine Administration: Induction of
Adipose Tissue Progestin Binding and Effect on Adipose
Tissue LPL Activity
Methods . Starting 4 days after OVX, rats received 3 daily injections
of either oil (n=9), E2B (2 ug/day; n=8), nafoxidine (2 mg/day; n=7),
or a combination of E2B and nafoxidine (n=8). Approximately 24 h after
the last injection, animals were sacrificed by decapitation and para-
metria! adipose depots were rapidly dissected. The left parametrial
pad was assayed for LPL activity and the right pad was assayed for
cytoplasmic progestin ((^H)R5020) binding.
Results . Both E2B and nafoxidine, alone and in combination, signifi-
cantly induced progestin binding sites in the cytoplasm of a para-
metrial fat tissue (Figure 12). At the doses used in this study,
nafoxidine was only half as effective as was E2B (16.4 vs. 30.4 fmol
(^H)R5020 specifically bound per mg protein, respectively) in the
induction of progestin receptors. Nafoxidine also significantly
Figure 11. Effect of administration of
various estrogens or antiestrogens of depletion
of cytoplasmic (2H)-estradiol binding sites and
induction of (3h)R5020 binding sites in parametrial
adipose depots of OVX-ADX rats.
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Figure 12. Effect of nafoxidine on the
induction of parametria! cytoplasmic (2h)R5020
binding sites and on parametria! adipose tissue
LPL activity.
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suppressed induction of progestin receptors <
.05, vs.
plus nafoxidine, t^ test).
Both E2B and nafoxidine, alone and in combination, depressed
adipose tissue LPL activity to 25% or less of control values (Figure
12). Nafoxidine was at least as effective as was E2B in lowering
LPL activity in this tissue. In combination with E2B, nafoxidine
further lowered, although not significantly (.10 < £ < .05, E2B vs.
I
E2B plus nafoxidine, t test), LPL activity in parametrial adipose
tissues (Figure 12).
i»
Experiment XIV. Concurrent Administration of Nafoxidine
and Progesterone: Effect on Adipose Tissue LPL
Activity
Methods
.
Beginning 4 days following surgery (OVX), animals received
3 daily injections of either oil (n=5), progesterone (5 mg/day;
n=6), E2B ( 2 ug/day; n=5), EgB plus progesterone (n=6), nafoxidine
(2 mg/day; n=6), nafoxidine plus progesterone (n=6), E2B plus
nafoxidine (n=6), or E2B plus nafoxidine plus progesterone (n=6). On
the day following the third injection, animals were sacrificed by
decapitation; parametrial fat tissue was removed; and LPL activity
was assayed.
Results . As was shown in the previous experiment, E2B nafoxidine and
the two compounds in combination significantly depressed adipose
tissue LPL activity (Figure 13). Although progesterone had no effect
on adipose tissue LPL activity when it was administered to oil-
treated animals, it reversed the E^B-induced suppression of LPL
Figure 13. Effect of concurrent admin-
istration of nafoxidine and progesterone on
parametria! adipose tissue LPL activity.
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activity (Figure 13). Progesterone had no effect on LPL activity in
nafoxidine-treated animals, and nafoxidine blocked the progesterone
reversal of E2B-induced suppression of LPL activity (Figure 13).
Discussion
The efficacy of various estrogens and antiestrogens in depleting
cytoplasmic estrogen receptors and inducing cytoplasmic progestin
binding sites was examined in parametrial adipose tissues (Experiment
XII). Those compounds which are known to mimic the effects of
estradiol on body weight (E2B, CI-628, nafoxidine; see Chapter III;
King and Cox, 1976) were found both to deplete available cytoplasmic
estrogen receptors and induce progestin binding sites (Figure 11).
Note that, while a single pulse of E2B, CI-628, and nafoxidine all
depleted estrogen receptors, E2B was much more effective than the
other compounds in inducing progestin receptors. The extent of
cytoplasmic receptor depletion, therefore, is not necessarily a good
indicator of the potency of an estrogen-like compound in inducing a
physiological response, such as the induction of progestin receptors.
In the doses used in this study, MER-25 (500 ug) and E^B (2 ug)
were ineffective in changing either estrogen or progestin binding
levels from control values (Figure 11). At these doses, E-jB and
MER-25 are ineffective in causing changes in estrogen receptor dis-
tribution in other tissues (Cidlowski and Muldoon, 1976) or in alter-
ing body weight or feeding behaviors, although at higher doses both
compounds do induce estrogen-like behaviors (Roy and Wade, 1976;
Wade, 1975).
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The effect of nafoxidine on the induction of progestin binding
sites was further examined, and another physiological endpoint,
i_.e. changes in adipose tissue LPL activity, was also examined in
nafoxidine-treated animals (Experiment XIII). Three days of
(2 ug/day) treatment resulted in a higher induction of progestin
binding sites than did 3 days of nafoxidine (2 mg/day) treatment,
alone or in combination with E2B. The amount of induced progestin
receptors seen in adipose tissues following nafoxidine, i .e .
approximately 50% of that seen in E2B-treated animals, is similar to
data previously reported for uterine progestin receptors (Leavitt
et al_.
,
1977). That is, nafoxidine induce, in both uterine and adi-
pose tissues, approximately half the progestin receptors induced
by E2B. In the same animals in which adipose tissue progestin bind-
ing was measured, however, nafoxidine was found to be at least as
effective as E2B in suppressing adipose tissue LPL activity (Figure
12).
Concurrent progesterone treatment increased LPL activity in E2B-
treated animals, although it had no effect in animals which were
treated with either nafoxidine, alone, or with nafoxidine plus
E2B (Figure 13). These data suggest that the progestin receptors
which were induced following nafoxidine treatment were either
qualitatively or quantitatively insufficient to promote progestin-
induced responses following progesterone administration. That is.
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either the receptors which were induced by nafoxidine were abnormal,
or there is a threshold number of receptors needed before a
physiological response can be manifested, and this amount was not
reached. Which hypothesis is the more valid one remains to be
elucidated.
CHAPTER VII
GENERAL DISCUSSION
The effects of two progestins (i.e. the natural compound, pro-
gesterone, and the synthetic compound, R5020) were examined with
regard to food intake, body weight and carcass composition regulation.
In all cases examined, R5020 was at least as effective in inducing
progestin-typical responses, and R5020 exerted its effects at much
lower (1/50 the dose required of progesterone) doses than progesterone.
Responses to the two compounds were qualitatively similar, although at
the doses used, R5020 sometimes induced greater effects. For the
purpose of further discussion, the actions of progesterone and R5020
will be considered to be similar and will be discussed in terms of
progestin-induced effects.
Progestin Effects on Carcass Composition and Adiposity
Ovarian hormones have multiple effects on regulatory behaviors
and metabolic processes. Estrogens decrease and, in the presence of
estrogens, progestins increase food intake, body weight gain and adi-
posity. These results were replicated in Experiments I-III (Chapter
II). It was expected that the changes in total carcass fat content
following hormone manipulation would be reflected in changes in para-
metrial adipose pad and cell size. Such changes had previously been
reported in the parametrial depots of intact animals which had been
treated with progesterone (Steingrimsdottir, Brasel and Greenwood,
1980) or estradiol benzoate (Salens, 1971 ) . Upton (1980), using OVX
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rats, was unable to demonstrate hormone induced changes in parametria!
adipose tissue cellularity. Reasons for the discrepancy in data are
unclear, although two possibilities should be considered. First there
were methodological differences between the studies. Upton (1980) and
I both used OVX, as opposed to gonadal ly intact, animals. We also
both used the modified photomicrography method for determining adipose
cell diameters as described in Experiment III. Steingrimsdottir and
colleagues, on the other hand, used an electronic counting system of
osmium fixed cells, a method which is supposedly more sensitive. A
second possibility is that hormone treatment altered cell size
distribution, not uniformly altering cell size alone. Faust et al_.
(1978) have demonstrated that after adipose cells reach a certain maxi-
mum size, they stop growing and further adipose tissue expansion is
manifested by the maturation and filling of smaller "pre-adipocytes"
.
In this way, factors which increase adipose pad weight might result
in increases in both very large and very small cells, thus not altering
the mean cell size. The result of this sort of change would be non-
significant changes in mean cell size, but large within pad cell
size variances. In order to verify or disprove this possibility, it
would be necessary to measure the distribution of cell diameters, not
just the mean cell size within hormone treatments.
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Progestin Effects on Adipose Tissue LPL Activity and
Progestin Binding in Adipose Depots
Both estrogens and estrogen plus progesterone treatment induce
serum hypertriglyceridemia (Experiment IV; Kim and Kalkoff, 1975; 1978).
Much of the hormone induced increase in circulating triglyceride
levels is the result of greatly enhanced hepatic production of hepatic
triglycerides, particularly very low density lipoprotein (VLDL)-
triglyceride (Chan et._al
. ,
1977; Heimberg et al_.
, 1978; Watkins,
Fizette and Heimberg, 1972; Weinstein, Seltzer and Belitsky, 1974).
Progestin administration to gonadally intact rats also results in
enhanced activities of several lipogenic enzymes (Dahm, Miagawa and
Jellinek, 1977; Dahm et al. , 1978).
In parallel with their effects on adiposity, estrogens (e.£. EgB)
decrease and progestins increase adipose tissue LPL activity (Experi-
ments XI and XIV; Hamosh and Hamosh, 1975; Kim and Kalkoff, 1975; 1978;
Steingrimsdottir, Brasel and Greenwood, 1980). These changes in LPL
activity might be regulated by apoprotein cofactors of hepatic
origin (Blum and Levy, 1975; Tan, 1978). Hormone administration
alters the ratio of inhibitory and activating apoproteins which are
produced by the liver (Kim and Kalkoff, 1978). LPL activity might
also be directly influenced by ovarian steroids at the level of the
adipocyte. High affinity, hormone specific binding sites for both
estrogens (Wade and Gray, 1978) and progestins (Chapter IV) were
demonstrated in parametrial adipose depots. The receptors are
depleted following hormone administration, presumably reflecting
translocation of steroid-receptor complexes into the nucleus. We
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have demonstrated, with (3H)-estradiol
, that following an injection of
radioactively labelled steroid, there is nuclear accumulation of
radioactivity. These data suggest that adipose tissues are true
target organs for steroid hormones. If so, one would expect that
steroids would have direct effects on the activities of adipose tissue
enzymes, perhaps including LPL.
Steingrimsdottir, Brasel and Greenwood (1980) have shown that
progesterone has no effect on the rate of adipose tissue lipolysis
(glycerol release). Of the three parameters which have been studied,
therefore, i.e. adipose tissue lipolysis, adipose tissue LPL activity
and serum triglyceride levels, the direction of clearance of
triglycerides into adipose tissues most closely reflects the behavioral
and gross metabolic changes which are observed following hormone
administration.
The greatest change in LPL activity following progestin treatment
appears to be in the parametrial fat depot, the pad in which there is
the highest induction of progestin-specific, high affinity binding
sites (Chapter IV). Hormone-induced changes in LPL activity are
found prior to changes in food intake after (Ramirez, unpublished
data) and progesterone (Steingrimsdottir, Brasel and Greenwood, 1980).
These data indicate that changes in adipose tissue LPL activity might
be of primary importance in initiating the chain of metabolic and
behavioral events which follow hormone manipulation.
Antiestrogen-Proqesterone Interactions
However, changes in adipose tissue LPL activity appear not to
be necessary for the changes in food intake, body weight gain and
carcass lipid content following progesterone treatment. Although the
"antiestrogen", nafoxidine, mimics the effects of estradiol and
lowers adipose tissue LPL activity (Experiments XIII, XIV), concurrent
progesterone treatment did not reverse LPL activity, as is normally
seen with progesterone when it is given concurrently with estrogens.
However, progesterone still manifested its full lipogenic effects
when it was injected into nafoxidine-treated rats (Experiment IV),
despite the fact that it did not alter parametrial adipose tissue LPL
activity (Experiment XIV). While it is possible that progesterone
exerted its effects on LPL activity in other fat depots of nafoxidine-
treated animals, this is highly unlikely. Parametrial pads have the
highest capacity for induction of progestin binding sites (Experiment
VII), and regional studies in estrogen treated animals indicate that
the parametrial depot LPL activity is far more responsive to progestin
treatment than are other depots (Experiment XI; Steingrimsdottir,
Brasel and Greenwood, 1980).
Nafoxidine also prevented the normally seen rise in serus trigly-
ceride levels. Progesterone treatment did not increase triglyceride
levels over nafoxidine-treated rats' values as it did after E2B treat-
meant (Experiment IV). Yet progesterone was completely effective in
increasing body weight and carcass lipid content in nafoxidine-treated
rats.
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To date, no one has studied the effects of ovarian hormones or
antiestrogens on adipose tissue lipogenesis. Adipose tissue is a
major site of fatty acid synthesis and esterif ication into trigly-
cerides (Newsholme and Start, 1973). Presumably if progesterone is
altering the amount of lipid in the adipose depots without changing
the amount of lipid which is entering the pad (as is found under the
nafoxidine plus progesterone condition) as demonstrated by a lack of
an effect on tissue LPL activity, then the hormone must be exerting
some effect on de novo fatty acid/triglyceride synthesis within the
pad. Further research is needed to test this hypothesis.
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FOOTNOTES
1. Trivial names used in this report, and their proper chemical
names, are: R5020, 17a, 21-dimethyl-19-norpregna-4,9-diene-
3,20-dione; nafoxidine, 1-(1 (£-3,4-dihydro-6-methoxy-2
phenyl naphth-1
-61 )-phenoxy)ethyl -pyrrolidine; MER-25,l-yl
(£-2-di ethyl ami no-ethoxyphenyl )-l -phenyl -2-methoxy-
phenylethanol ; CI-628, a-(4-pyrrol idinethoxy)phenyl-4-
methoxy-a-ni trosti 1 bene.
2. Serum triglyceride and glycerol levels were generously assayed
by Dr. Israel Ramirez.
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